• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

体外筛选的耐替加环素耐甲氧西林金黄色葡萄球菌序列型5中的耐药性由mepR和mepA基因突变驱动。

Resistance in In Vitro Selected Tigecycline-Resistant Methicillin-Resistant Staphylococcus aureus Sequence Type 5 Is Driven by Mutations in mepR and mepA Genes.

作者信息

Dabul Andrei Nicoli Gebieluca, Avaca-Crusca Juliana Sposto, Van Tyne Daria, Gilmore Michael S, Camargo Ilana Lopes Baratella Cunha

机构信息

1 Department of Physics and Interdisciplinary Science, São Carlos Institute of Physics, University of São Paulo , São Carlos, Brazil .

2 Department of Ophthalmology, Harvard Medical School , Massachusetts Eye and Ear Infirmary, Boston, Massachusetts.

出版信息

Microb Drug Resist. 2018 Jun;24(5):519-526. doi: 10.1089/mdr.2017.0279. Epub 2017 Oct 17.

DOI:10.1089/mdr.2017.0279
PMID:29039719
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6037189/
Abstract

A tigecycline-susceptible (TGC-S) Sequence Type (ST) 5 clinical methicillin-resistant Staphylococcus aureus (MRSA) strain was cultured in escalating levels of tigecycline, yielding mutants eightfold more resistant. Their genomes were sequenced to identify genetic alterations, resulting in resistance. Alterations in rpsJ, commonly related to tigecycline resistance, were also investigated. Tigecycline resistance was mediated by loss-of-function mutations in the transcriptional repressor mepR, resulting in derepression of the efflux pump mepA. Increased levels of resistance were obtained by successive mutations in mepA itself. No alterations in RpsJ were observed in selected strains, but we observed a K57M substitution, previously correlated with resistance, among TGC-S clinical strains. Thus, the pathway to tigecycline resistance in CC5 MRSA in vitro appears to be derepression of mep operon as the result of mepR loss-of-function mutation, followed by alterations in MepA efflux pump. This shows that other evolutionary pathways, besides mutation of rpsJ, are available for evolving tigecycline resistance in CC5 MRSA.

摘要

一株对替加环素敏感(TGC-S)的序列型(ST)5临床耐甲氧西林金黄色葡萄球菌(MRSA)菌株在逐步增加的替加环素浓度中培养,产生了耐药性提高八倍的突变体。对它们的基因组进行测序以鉴定导致耐药性的基因改变。还研究了通常与替加环素耐药性相关的rpsJ中的改变。替加环素耐药性由转录阻遏物mepR的功能丧失突变介导,导致外排泵mepA的去阻遏。通过mepA自身的连续突变获得了更高水平的耐药性。在选定的菌株中未观察到RpsJ的改变,但我们在TGC-S临床菌株中观察到先前与耐药性相关的K57M替换。因此,CC5 MRSA体外对替加环素耐药的途径似乎是由于mepR功能丧失突变导致mep操纵子去阻遏,随后是MepA外排泵的改变。这表明除了rpsJ突变之外,其他进化途径也可导致CC5 MRSA产生替加环素耐药性。

相似文献

1
Resistance in In Vitro Selected Tigecycline-Resistant Methicillin-Resistant Staphylococcus aureus Sequence Type 5 Is Driven by Mutations in mepR and mepA Genes.体外筛选的耐替加环素耐甲氧西林金黄色葡萄球菌序列型5中的耐药性由mepR和mepA基因突变驱动。
Microb Drug Resist. 2018 Jun;24(5):519-526. doi: 10.1089/mdr.2017.0279. Epub 2017 Oct 17.
2
Mutations in the MepRAB efflux system contribute to the in vitro development of tigecycline resistance in Staphylococcus aureus.MepRAB 外排系统的突变导致金黄色葡萄球菌对替加环素的体外耐药性发展。
J Glob Antimicrob Resist. 2020 Sep;22:631-636. doi: 10.1016/j.jgar.2020.06.005. Epub 2020 Jun 23.
3
Genetic changes associated with tigecycline resistance in Staphylococcus aureus in vitro-selected mutants belonging to different lineages.金黄色葡萄球菌体外选择突变株中与替加环素耐药相关的遗传变化,这些突变株属于不同的谱系。
Int J Antimicrob Agents. 2021 Apr;57(4):106304. doi: 10.1016/j.ijantimicag.2021.106304. Epub 2021 Feb 12.
4
Tigecycline Resistance-Associated Mutations in the MepA Efflux Pump in Staphylococcus aureus.金黄色葡萄球菌中 MepA 外排泵相关的替加环素耐药突变。
Microbiol Spectr. 2023 Aug 17;11(4):e0063423. doi: 10.1128/spectrum.00634-23. Epub 2023 Jul 11.
5
A novel MATE family efflux pump contributes to the reduced susceptibility of laboratory-derived Staphylococcus aureus mutants to tigecycline.一种新型的多药及毒素外排(MATE)家族外排泵导致实验室衍生的金黄色葡萄球菌突变体对替加环素的敏感性降低。
Antimicrob Agents Chemother. 2005 May;49(5):1865-71. doi: 10.1128/AAC.49.5.1865-1871.2005.
6
First description of rpsJ and mepA mutations associated with tigecycline resistance in Staphylococcus aureus isolated from a cystic fibrosis patient during antibiotic therapy.首次描述在抗生素治疗期间从一名囊性纤维化患者分离出的金黄色葡萄球菌中与替加环素耐药性相关的rpsJ和mepA突变。
Int J Antimicrob Agents. 2017 Dec;50(6):739-741. doi: 10.1016/j.ijantimicag.2017.10.003. Epub 2017 Oct 13.
7
Mutations at the Ribosomal S10 Gene in Clinical Strains of Staphylococcus aureus with Reduced Susceptibility to Tigecycline.核糖体 S10 基因在对替加环素敏感性降低的金黄色葡萄球菌临床株中的突变。
Antimicrob Agents Chemother. 2017 Dec 21;62(1). doi: 10.1128/AAC.01852-17. Print 2018 Jan.
8
The molecular mechanisms of allosteric mutations impairing MepR repressor function in multidrug-resistant strains of Staphylococcus aureus.变构突变影响金黄色葡萄球菌多药耐药株 MepR 阻遏物功能的分子机制。
mBio. 2013 Aug 27;4(5):e00528-13. doi: 10.1128/mBio.00528-13.
9
In vitro activity of tigecycline against methicillin-resistant Staphylococcus aureus, including livestock-associated strains.替加环素对耐甲氧西林金黄色葡萄球菌(包括与家畜相关的菌株)的体外活性。
Eur J Clin Microbiol Infect Dis. 2010 May;29(5):503-7. doi: 10.1007/s10096-010-0886-2. Epub 2010 Feb 26.
10
[In vitro activity of tigecycline against methicillin-resistant staphylococci].替加环素对耐甲氧西林葡萄球菌的体外活性
Mikrobiyol Bul. 2009 Apr;43(2):211-5.

引用本文的文献

1
Unmasking MRSA's Armor: Molecular Mechanisms of Resistance and Pioneering Therapeutic Countermeasures.揭开耐甲氧西林金黄色葡萄球菌的“铠甲”:耐药分子机制及开创性治疗对策
Microorganisms. 2025 Aug 18;13(8):1928. doi: 10.3390/microorganisms13081928.
2
Phenotypic and genetic stepwise changes in during adaptive laboratory evolution under the selective pressure of tigecycline.在替加环素的选择压力下适应性实验室进化过程中的表型和遗传逐步变化。
Antimicrob Agents Chemother. 2025 May 7;69(5):e0007225. doi: 10.1128/aac.00072-25. Epub 2025 Mar 26.
3
Optimizing Bothropstoxin-I-Derived Peptides: Exploring the Antibacterial Potential of p-BthW.优化源自矛头蝮毒素-I的肽:探索p-BthW的抗菌潜力。
ACS Omega. 2024 May 22;9(22):23662-23674. doi: 10.1021/acsomega.4c01303. eCollection 2024 Jun 4.
4
Staph wars: the antibiotic pipeline strikes back.葡萄球菌之战:抗生素管道奋起反击。
Microbiology (Reading). 2023 Sep;169(9). doi: 10.1099/mic.0.001387.
5
Tigecycline Resistance-Associated Mutations in the MepA Efflux Pump in Staphylococcus aureus.金黄色葡萄球菌中 MepA 外排泵相关的替加环素耐药突变。
Microbiol Spectr. 2023 Aug 17;11(4):e0063423. doi: 10.1128/spectrum.00634-23. Epub 2023 Jul 11.
6
Atopic dermatitis-derived strains: what makes them special in the interplay with the host.特应性皮炎相关菌株:它们在与宿主相互作用中有何特别之处。
Front Cell Infect Microbiol. 2023 Jun 14;13:1194254. doi: 10.3389/fcimb.2023.1194254. eCollection 2023.
7
Antimicrobial Activity of an Fmoc-Plantaricin 149 Derivative Peptide against Multidrug-Resistant Bacteria.Fmoc-植物乳杆菌素149衍生肽对多重耐药菌的抗菌活性
Antibiotics (Basel). 2023 Feb 15;12(2):391. doi: 10.3390/antibiotics12020391.
8
antimicrobial activity and resistance mechanisms of the new generation tetracycline agents, eravacycline, omadacycline, and tigecycline against clinical isolates.新一代四环素类药物依拉环素、奥马环素和替加环素对临床分离株的抗菌活性及耐药机制
Front Microbiol. 2022 Nov 22;13:1043736. doi: 10.3389/fmicb.2022.1043736. eCollection 2022.
9
Genomic Insights of First B-Positive ST338-SCCV/CC59 Taiwan Clone of Community-Associated Methicillin-Resistant in Poland.波兰社区相关耐甲氧西林金黄色葡萄球菌 ST338-SCCV/CC59 型 B 族首报克隆的基因组分析
Int J Mol Sci. 2022 Aug 6;23(15):8755. doi: 10.3390/ijms23158755.
10
Essential Oil: Exploring the Antibacterial Multitarget Mechanisms, Chemcomputational Toxicity Prediction, and Safety Assessment in Zebrafish Embryos.精油:探究其多靶点抗菌机制、斑马鱼胚胎的化学计算毒性预测和安全性评估。
Molecules. 2022 Apr 19;27(9):2630. doi: 10.3390/molecules27092630.

本文引用的文献

1
The drug-resistant bacteria that pose the greatest health threats.构成最大健康威胁的耐药细菌。
Nature. 2017 Feb 28;543(7643):15. doi: 10.1038/nature.2017.21550.
2
Step-Wise Increase in Tigecycline Resistance in Klebsiella pneumoniae Associated with Mutations in ramR, lon and rpsJ.肺炎克雷伯菌中与ramR、lon和rpsJ突变相关的替加环素耐药性逐步增加
PLoS One. 2016 Oct 20;11(10):e0165019. doi: 10.1371/journal.pone.0165019. eCollection 2016.
3
Rapid emergence of high-level tigecycline resistance in Escherichia coli strains harbouring blaNDM-5 in vivo.携带 blaNDM-5 的大肠杆菌菌株体内出现高水平替加环素耐药性的快速出现。
Int J Antimicrob Agents. 2016 Apr;47(4):324-7. doi: 10.1016/j.ijantimicag.2016.01.005. Epub 2016 Feb 15.
4
Mechanisms of Resistance, Clonal Expansion, and Increasing Prevalence of Acinetobacter baumannii Strains Displaying Elevated Tigecycline MIC Values in Latin America.拉丁美洲鲍曼不动杆菌菌株对替加环素的最低抑菌浓度(MIC)值升高的耐药机制、克隆扩增及流行率增加情况
Microb Drug Resist. 2016 Jun;22(4):253-8. doi: 10.1089/mdr.2015.0168. Epub 2015 Dec 30.
5
Tigecycline resistance in clinical isolates of Enterococcus faecium is mediated by an upregulation of plasmid-encoded tetracycline determinants tet(L) and tet(M).屎肠球菌临床分离株中的替加环素耐药性是由质粒编码的四环素决定簇 tet(L) 和 tet(M) 的上调介导的。
J Antimicrob Chemother. 2016 Apr;71(4):871-81. doi: 10.1093/jac/dkv420. Epub 2015 Dec 18.
6
Efficacy and safety of tigecycline for the treatment of severe infectious diseases: an updated meta-analysis of RCTs.替加环素治疗严重感染性疾病的疗效和安全性:RCT 的更新荟萃分析。
Int J Infect Dis. 2015 Oct;39:25-33. doi: 10.1016/j.ijid.2015.08.009. Epub 2015 Aug 15.
7
The ribosomal S10 protein is a general target for decreased tigecycline susceptibility.核糖体S10蛋白是替加环素敏感性降低的一个常见靶点。
Antimicrob Agents Chemother. 2015 Sep;59(9):5561-6. doi: 10.1128/AAC.00547-15. Epub 2015 Jun 29.
8
The genetic basis of the fitness costs of antimicrobial resistance: a meta-analysis approach.抗菌药物耐药性的适应性成本的遗传基础:荟萃分析方法。
Evol Appl. 2015 Mar;8(3):284-95. doi: 10.1111/eva.12202. Epub 2014 Dec 12.
9
Tigecycline susceptibility and the role of efflux pumps in tigecycline resistance in KPC-producing Klebsiella pneumoniae.替加环素敏感性及外排泵在产KPC肺炎克雷伯菌对替加环素耐药中的作用
PLoS One. 2015 Mar 3;10(3):e0119064. doi: 10.1371/journal.pone.0119064. eCollection 2015.
10
Mutations within the mepA operator affect binding of the MepR regulatory protein and its induction by MepA substrates in Staphylococcus aureus.mepA 操纵子内的突变会影响金黄色葡萄球菌中 MepR 调节蛋白的结合及其被 MepA 底物诱导的过程。
J Bacteriol. 2015 Mar;197(6):1104-14. doi: 10.1128/JB.02558-14. Epub 2015 Jan 12.